Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience
Access Status
Fulltext not available
Authors
Ward, Natalie
Pang, J.
Ryan, J.
Watts, G.
Date
2018Type
Journal Article
Metadata
Show full item recordCitation
Ward, N. and Pang, J. and Ryan, J. and Watts, G. 2018. Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience. Clinical Cardiology. 41 (1): pp. 159-165.
Source Title
Clinical Cardiology
ISSN
School
School of Public Health
Collection
Abstract
There is considerable evidence for the role of low-density lipoprotein cholesterol (LDL-C) in the development of atherosclerotic cardiovascular disease. Although statin therapy remains the most frequency prescribed medication to reduce LDL-C and lower risk of cardiovascular disease, a considerable number of patients develop muscle-related side affects. This review summarizes recent literature supporting the role of nutraceuticals as LDL-C–lowering therapy in statin-intolerant patients, with evidence from our own clinical practices.